• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Carl Zeiss Meditec introduces new treatment workflow, data management systems

Article

Carl Zeiss Meditec introduced its new suite of treatment workflow and data management systems at the annual meeting of the American Academy of Ophthalmology.

San Francisco

-Carl Zeiss Meditec introduced its new suite of treatment workflow and data management systems at the annual meeting of the American Academy of Ophthalmology.

“Our solutions are designed to help ophthalmologists in today’s health-care environment to achieve greater workflow efficiencies while obtaining superior clinical results through better combination and integration of their diagnostic and treatment modalities,” said Michael Kaschke, president and chief executive officer, Carl Zeiss Meditec.

One platform (Zeiss Ophthalmic Data Management Solution) stores all diagnostic patient data to provide a paperless diagnostic and surgical workflow. It connects all ophthalmic systems, links diagnostic and surgery devices, and includes an FDA-cleared eye-care data-management system (Forum) and an operating room management system (Callisto eye).

Another combination of tools (Zeiss Toric Solution) is designed to allow physicians to perform cataract surgery more efficiently and to implant and align toric lenses more quickly and easily. The tools include a partial coherence interferometer (IOL Master); surgical microscopes (including the OPMI Lumera 700); the aforementioned operating room management system, which includes a video-supported tool (Z Align); an online calculator (Z Calc); and a toric IOL (AT LISA, not approved for sale in the United States).

Another range of applications (Zeiss Refractive Laser Solution) is designed to offer a fully integrated flow of data and patient handling. The applications include an excimer laser (MEL 80), a custom treatment platform (CRS-Master), and a femtosecond laser (VisuMax).

A workstation including the excimer and femtosecond lasers is being evaluated at four centers within the United States. Outcomes of a LASIK procedure (FLEx) using the lasers outside of the United States are expected to be presented during the 2010 annual meeting of the American Society of Cataract and Refractive Surgery, according to the company.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.